Dual-Locked Near-Infrared Fluorescent Probe for Real-Time Imaging of Hydrogen Sulfide/Matrix Metallopeptidase-2 In Vivo.

ACS Nano

State Key Laboratory of Flexible Electronics (LoFE), Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), School of Materials Science and Engineering, Nanjing University of Posts and Telecommunicat

Published: February 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Hydrogen sulfide (HS) and matrix metallopeptidase 2 (MMP-2) are inextricably linked in the occurrence and development of diseases and the treatment of diseases. However, most of the activatable imaging probes currently developed are single-locked probes that do not simultaneously detect HS and MMP-2 levels at disease sites and severely hinder the real-time and accurate analysis of the dynamic relationship between the two interrelated biomarkers. Herein, we report a dual-locked HS/MMP-2-activatable near-infrared (NIR) fluorescent imaging probe through a dual-Förster resonance energy transfer (FRET) mechanism that specifically detects tumors or acute lung injury (ALI) and establishes the dynamic relationship between the HS level and MMP-2 expression. Initially, the fluorescence of the probe is turned off due to energy transfer from methylene blue (MB) to both the cationic electrochromic material (dicationic 1,1,4,4-tetraarylbutadiene, EM ) and quencher QSY21. Upon reaction with HS/MMP-2 in tumors or ALI, the NIR fluorescence of the probe is activated, enabling accurate real-time imaging of tumors or ALI. Additionally, this probe precisely tracks the effects of exogenous HS in tumors or glucocorticoids for the treatment of ALI on MMP-2 expression, providing a powerful molecular imaging tool for early prediction of treatment outcomes in tumors and ALI.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsnano.4c17799DOI Listing

Publication Analysis

Top Keywords

tumors ali
12
real-time imaging
8
dynamic relationship
8
energy transfer
8
mmp-2 expression
8
fluorescence probe
8
probe
5
imaging
5
tumors
5
ali
5

Similar Publications

Endometrial carcinoma is one of the most common gynecologic cancers worldwide. The condition typically occurs after menopause; however, young women under the age of 40 years can also be diagnosed with the disease. Providers may delay diagnosis in young patients due to nonspecific presentation or low clinical suspicion.

View Article and Find Full Text PDF

Introduction Stereotactic radiosurgery (SRS) is widely regarded as the standard of care after the resection of brain metastases in order to reduce local cavity recurrence risk. The objective of this study was to explore the reproducibility of published outcomes for patients receiving post-operative stereotactic radiosurgery (cavity SRS) in a National Health Service (NHS) setting for a non-selective series of patients. For our service, the median interval between surgery to cavity SRS (cSRS) is eight weeks, whereas similar timelines have been found to have a deleterious impact on survival in the published literature.

View Article and Find Full Text PDF

Rationale: Brown tumor (osteitis fibrosa cystica) is a benign bone lesion associated with hyperparathyroidism that can affect multiple bones in patients with end-stage renal disease (ESRD).

Patient Concerns: We present the case of a 32-year-old female with ESRD on maintenance hemodialysis who experienced body aches, muscle weakness, constipation, and mood swings for 3 months.

Diagnoses: Initial tests revealed elevated parathyroid hormone (PTH), serum calcium, and phosphorus levels.

View Article and Find Full Text PDF

CDK7 has emerged as a cancer target because of its pivotal roles in cell cycle progression and transcription. Several CDK7 inhibitors (CDK7i) are now in clinical evaluation. Identifying patients most likely to respond to treatment and early detection of tumour evolution towards resistance are necessary for optimal implementation of cancer therapies.

View Article and Find Full Text PDF

Chronic myelomonocytic leukemia (CMML) is an aggressive hematologic neoplasm characterized by an expansion of CD123 monocytes and plasmacytoid dendritic cells (pDCs). pDC bone marrow clusters in CMML have been associated with higher rates of acute myeloid leukemia transformation. We evaluated tagraxofusp, a CD123-targeted therapy, in a phase 1/2 trial for patients with CMML.

View Article and Find Full Text PDF